XYMOGEN
Violation History
1 incident
Fda Warning
The warning letter cited violations of current Good Manufacturing Practice (cGMP) regulations for dietary supplements, including failure to establish product specifications for the identity, purity, strength, and composition of the finished dietary supplement, and failure to conduct at least one appropriate test or examination to verify the identity of a dietary ingredient. The letter also noted that several products were considered new drugs because they were not generally recognized as safe and effective for their intended use.2011-12-13Source
Xcellent A 37500, 60 Vegetarian Capsules
Product 93
Brand 96
NiaVasc, 360 Tablets
Product 93
Brand 96
NiaVasc 750, 60 Tablets
Product 93
Brand 96
D3 50,000, 30 Vegetarian Capsules
Product 93
Brand 96
NiaVasc 750, 120 Tablets
Product 93
Brand 96
Methylcobalamin, 60 Quick-Dissolve Tablets
Product 93
Brand 96
D3 5000, 60 Softgels
Product 93
Brand 96
Methylcobalamin, 120 Quick-DissolveTablets
Product 93
Brand 96
D3 5000, 90 Softgels
Product 93
Brand 96
ColonX, 60 Vegetarian Capsules
Product 93
Brand 96
Scan Any Supplement Instantly
Download GoodSupp to scan barcodes and check any XYMOGEN product.
Disclaimer: GoodSupp provides independent supplement quality analysis for informational purposes only. Scores are generated algorithmically based on ingredient profiles, brand certifications, and public records. This is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Product data is sourced from manufacturer labels and public databases. GoodSupp is not affiliated with any supplement brand.